1

Mahavir Advanced Remedies

111489

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Company is almost debt free.

Weaknesses

3
  • Stock is trading at 19.2 times its book value
  • Company has a low return on equity of -2.33% over last 3 years.
  • Working capital days have increased from 17,954 days to 30,258 days

Growth Rate

Revenue Growth
82% higher than 3Y
Net Income Growth
—

Quarterly Results

Particulars Mar 2013Jun 2013Sep 2013Dec 2013Mar 2014Jun 2014Sep 2014Dec 2014
Sales
0.02
0.03
0.03
0.03
0.02
0.02
0.13
0.03
Expenses
0.08
0.02
0.01
0.01
0.15
0.01
0.02
0.02
Operating Profit
-0.06
0.01
0.02
0.02
-0.13
0.01
0.11
0.01
OPM %
-300%
33.33%
66.67%
66.67%
-650%
50%
84.62%
33.33%
Other Income
0
0
-0.04
0
0.26
0
0
0
Interest
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
PBT
-0.06
0.01
-0.02
0.02
0.13
0.01
0.11
0.01
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
Net Profit
-0.06
0.01
-0.02
0.02
0.13
0.01
0.11
0.01
EPS in Rs
-0.05
0.01
-0.02
0.02
0.11
0.01
0.1
0.01
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014TTM
Sales
0.19
0.24
0.21
0.14
0.1
0.2
Expenses
0.21
0.25
0.53
0.3
0.18
0.2
Operating Profit
-0.02
-0.01
-0.32
-0.16
-0.08
0
OPM %
-10.53%
-4.17%
-152.38%
-114.29%
-80%
0%
Other Income
0
0
0
0.01
0.22
0.26
Interest
0
0
0
0
0
0
Depreciation
0.04
0.04
0
0
0
0
PBT
-0.06
-0.05
-0.32
-0.15
0.14
0.26
Tax %
0%
0%
0%
0%
0%
—
Net Profit
-0.06
-0.05
-0.32
-0.15
0.14
0.26
EPS in Rs
—
—
—
-0.13
0.12
0.23
Div. Payout %
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Sep 2014
Equity Capital
3.76
3.76
3.76
11.36
11.36
11.36
Reserves
-2.82
-2.87
-3.11
-2.71
-2.57
-2.45
Borrowings
0
0
0
0
0
0
Other Liabilities
0.16
0.15
0.06
0
0.01
0.01
Total Liabilities
1.1
1.04
0.71
8.65
8.8
8.92
Fixed Assets
0.49
0.45
0
0
0
0
CWIP
0
0
0
0
0
0
Investments
0
0
0
0
0
0
Other Assets
0.61
0.59
0.71
8.65
8.8
8.92
Total Assets
1.1
1.04
0.71
8.65
8.8
8.92
Figures in ₹ Crores

Cash Flow

Particulars Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014
Operating
0
-0.01
0.01
-8.17
0.48
Investing
0
0
0.01
0
0
Financing
0
0
0
8.16
0
Net Cash Flow
0
-0.01
0.02
-0.01
0.48
Free Cash Flow
0
-0.01
0.12
-8.17
0.48
CFO/OP
0
100
-3
5,106
-600
Figures in ₹ Crores

Ratios

Particulars Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014
Debtor Days
211
167
191
0
0
Inventory Days
0
0
—
—
—
Cash Conversion Cycle
211
167
191
0
0
Working Capital Days
76.84
183
1,078
22,526
30,259
ROCE %
—
-5.46%
-41.56%
-3.23%
1.61%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Mahavir Advanced Remedies insights

41 extracted metrics + investor summaries across FY09–FY14.

Log in — free

Documents

Frequently Asked Questions about Mahavir Advanced Remedies

What does Mahavir Advanced Remedies Ltd do?
Mahavir Advanced Remedies Ltd is an India-based manufacturer and trading of tablet, liquid orals, capsules and ointments.
Which sector does Mahavir Advanced Remedies Ltd belong to?
Mahavir Advanced Remedies Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.

Company Information

Mahavir Advanced Remedies Ltd is an India-based manufacturer and trading of tablet, liquid orals, capsules and ointments.

Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/111489.md for Mahavir Advanced Remedies Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List